Follow The Filings

RLYB Rallybio

Rallybio earnings company data as of 11:02 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by RLYB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RLYB insider trades
  • $4.2M bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $227K 16,209 shares at $13.98 +1.8% to stake
    Traded May 18–19 Filed May 20
  2. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $1.1M 79,559 shares at $13.99 +9.6% to stake
    Traded May 13–15 Filed May 15
  3. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $711K 50,800 shares at $14.00 +6.5% to stake
    Traded May 11–12 Filed May 13
  4. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $2.2M 155,905 shares at $13.97 +25% to stake
    Traded May 4–5 Filed May 6

Also filed in the last 12 months, not counted as buying or selling: 12 option exercises, 1 stock grant, and 1 sale to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
424B3
8-K 5.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 1.01,3.02,5.01,5.02,7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
10-Q
SCHEDULE 13D/A —
8-K 1.02,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 5.02
10-K
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13D/A —
8-K 1.01,3.02,5.01,5.02,7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.